Lilly, Scribe team up for neuro diseases CRISPR therapies
room mom Scribe Therapeutics is partnering with the Eli Lilly unit (New York Stock Exchange: LLYTherapeutics prevail and grant rights to CRISPR X-Editing (XE) technologies to develop in vivo treatments for neuromuscular diseases. Under…
